Figure 7. The relationship between the signature and clinical characteristics of HCC patients. There was no difference in risk scores for patients of different ages (A) and genders (B). With the increase of grade (C, D), stage (E, F) and T classification (G, H), the risk had an upward trend. There was a significant difference in the with tumor and tumor free patients (I, J). The stage difference could be verified in the ICGC cohort (K, L).